These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 35429771)

  • 1. Multi-labeled neural network model for automatically processing cardiomyocyte mechanical beating signals in drug assessment.
    Ouyang Q; Yang W; Wu Y; Xu Z; Hu Y; Hu N; Zhang D
    Biosens Bioelectron; 2022 Aug; 209():114261. PubMed ID: 35429771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A biosensing system employing nonlinear dynamic analysis-assisted neural network for drug-induced cardiotoxicity assessment.
    Yang W; Ouyang Q; Zhu Z; Wu Y; Fan M; Liao Y; Guo X; Xu Z; Zhang X; Zhang Y; Hu N; Zhang D
    Biosens Bioelectron; 2023 Feb; 222():114923. PubMed ID: 36455375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal and Sensitive Drug Assessment Biosensing Platform Using Optimal Mechanical Beating Detection of Single Cardiomyocyte.
    Xu D; Xiao H; Wang S; Li H; Chen HJ; Liu C; Hu N
    ACS Nano; 2022 Sep; 16(9):15484-15494. PubMed ID: 36094397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of beating parameters in human induced pluripotent stem cells enables quantitative in vitro screening for cardiotoxicity.
    Sirenko O; Cromwell EF; Crittenden C; Wignall JA; Wright FA; Rusyn I
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):500-7. PubMed ID: 24095675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid Integrated Cardiomyocyte Biosensors for Bitter Detection and Cardiotoxicity Assessment.
    Wei X; Jiang D; Chen C; Wu J; Qin C; Yuan Q; Xue Y; Xiong Y; Zhuang L; Hu N; Wang P
    ACS Sens; 2021 Jul; 6(7):2593-2604. PubMed ID: 34253023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific recognition of ion channel blocker by high-content cardiomyocyte electromechanical integrated correlation.
    Li H; Fang J; Wei X; Xu D; Zhang T; Xiang Y; Chen HJ; Liu F; Xie X; Wang P; Hu N
    Biosens Bioelectron; 2020 Aug; 162():112273. PubMed ID: 32452396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiotoxicity screening of illicit drugs and new psychoactive substances (NPS) in human iPSC-derived cardiomyocytes using microelectrode array (MEA) recordings.
    Zwartsen A; de Korte T; Nacken P; de Lange DW; Westerink RHS; Hondebrink L
    J Mol Cell Cardiol; 2019 Nov; 136():102-112. PubMed ID: 31526813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bridging Functional and Structural Cardiotoxicity Assays Using Human Embryonic Stem Cell-Derived Cardiomyocytes for a More Comprehensive Risk Assessment.
    Clements M; Millar V; Williams AS; Kalinka S
    Toxicol Sci; 2015 Nov; 148(1):241-60. PubMed ID: 26259608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of in vitro models of stem cell-derived cardiomyocytes to screen for potential cardiotoxicity of chemicals.
    Shi M; Tien NT; de Haan L; Louisse J; Rietjens IMCM; Bouwmeester H
    Toxicol In Vitro; 2020 Sep; 67():104891. PubMed ID: 32446838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cardiomyocyte-based biosensor for antiarrhythmic drug evaluation by simultaneously monitoring cell growth and beating.
    Wang T; Hu N; Cao J; Wu J; Su K; Wang P
    Biosens Bioelectron; 2013 Nov; 49():9-13. PubMed ID: 23708811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Cardiotoxicity With Stem Cell-based Strategies.
    Stella Stoter AM; Hirt MN; Stenzig J; Weinberger F
    Clin Ther; 2020 Oct; 42(10):1892-1910. PubMed ID: 32938533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Cardiac Safety Assessment using hiPS-cardiomyocytes (Consortium for Safety Assessment using Human iPS Cells: CSAHi).
    Takasuna K; Kazusa K; Hayakawa T
    Curr Pharm Biotechnol; 2020; 21(9):829-841. PubMed ID: 31749424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electromechanical integrated recording of single cardiomyocyte in situ by multimodal microelectrode biosensing system.
    Zhang D; Xiang Y; Zou Q; Zhu K; Hu N
    Biosens Bioelectron; 2022 Sep; 212():114387. PubMed ID: 35635972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Next-Generation Biosensing Platform for Simultaneous Detection of Mechano- and Electrophysiology of the Drug-Induced Cardiomyocytes.
    Oyunbaatar NE; Dai Y; Shanmugasundaram A; Lee BK; Kim ES; Lee DW
    ACS Sens; 2019 Oct; 4(10):2623-2630. PubMed ID: 31535848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional screening in human induced-pluripotent stem cell-derived cardiomyocytes accurately identifies cardiotoxicity of multiple drug types.
    Doherty KR; Talbert DR; Trusk PB; Moran DM; Shell SA; Bacus S
    Toxicol Appl Pharmacol; 2015 May; 285(1):51-60. PubMed ID: 25841593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthracycline-Induced Cardiotoxicity: Molecular Insights Obtained from Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs).
    Bozza WP; Takeda K; Alterovitz WL; Chou CK; Shen RF; Zhang B
    AAPS J; 2021 Mar; 23(2):44. PubMed ID: 33719006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance beating pattern function of human induced pluripotent stem cell-derived cardiomyocyte-based biosensors for hERG inhibition recognition.
    Hu N; Wang T; Wang Q; Zhou J; Zou L; Su K; Wu J; Wang P
    Biosens Bioelectron; 2015 May; 67():146-53. PubMed ID: 25153933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Induced Pluripotent Stem-Cardiac-Endothelial-Tumor-on-a-Chip to Assess Anticancer Efficacy and Cardiotoxicity.
    Weng KC; Kurokawa YK; Hajek BS; Paladin JA; Shirure VS; George SC
    Tissue Eng Part C Methods; 2020 Jan; 26(1):44-55. PubMed ID: 31797733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Workshop Report: FDA Workshop on Improving Cardiotoxicity Assessment With Human-Relevant Platforms.
    Pang L; Sager P; Yang X; Shi H; Sannajust F; Brock M; Wu JC; Abi-Gerges N; Lyn-Cook B; Berridge BR; Stockbridge N
    Circ Res; 2019 Oct; 125(9):855-867. PubMed ID: 31600125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action potential-based MEA platform for in vitro screening of drug-induced cardiotoxicity using human iPSCs and rat neonatal myocytes.
    Jans D; Callewaert G; Krylychkina O; Hoffman L; Gullo F; Prodanov D; Braeken D
    J Pharmacol Toxicol Methods; 2017 Sep; 87():48-52. PubMed ID: 28549786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.